Mission Bio Stock

missionbio.comBioTechFounded: 2014Funding to Date: $114.72MM

Mission Bio is the developer of the Tapestri Platform which is a single-cell multi-omics platform enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. This company was founded in 2014 by Adam Abate, Adam Sciambi, Charlie Silver and Dennis Eastburn and is headquartered in San Francisco, CA. Mission Bio helps researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Mission Bio, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Mission Bio.

Register Today
Register for Details

For more details on financing and valuation for Mission Bio, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Mission Bio investors also invested in these private companies

Novo Holdings
Agilent Technologies
Cota Capital

Team

Management Team

Yan Zhang
Chief Executive Officer
Marcel Roche
Chief Financial Officer
Darrin Crisitello
Chief Commercial Officer
Adam Sciambi
Co-Founder and Senior Director, Technology & Systems

Other companies like Mission Bio in the BioTech sector

Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.89B